Cerebrospinal fluid (CSF) neurofilament light (NfL) is a reliable marker of neuro-axonal damage in different neurological disorders that is related to disease severity. To date, all recent studies performed in human CSF have used the same enzyme-linked immunosorbent assay (ELISA). To confirm the large body of evidence for NfL, we developed a new ELISA method and here we present the performance characteristics of this new ELISA for CSF NfL in different neurological disorders.
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation
Gaetani, Lorenzo;Parnetti, Lucilla;Eusebi, Paolo;Sarchielli, Paola;Calabresi, Paolo;Di Filippo, Massimiliano;
2018
Abstract
Cerebrospinal fluid (CSF) neurofilament light (NfL) is a reliable marker of neuro-axonal damage in different neurological disorders that is related to disease severity. To date, all recent studies performed in human CSF have used the same enzyme-linked immunosorbent assay (ELISA). To confirm the large body of evidence for NfL, we developed a new ELISA method and here we present the performance characteristics of this new ELISA for CSF NfL in different neurological disorders.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gaetani et al., Alzh Res Ter, 2018.pdf
accesso aperto
Tipologia di allegato:
PDF-editoriale
Licenza:
Creative commons
Dimensione
845.67 kB
Formato
Adobe PDF
|
845.67 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
